Abstract:Long-term nonsteroidal anti-inflammatory drugs (NSAIDs) therapy has been associated with several adverse effects such as gastric ulceration and cardiovascular events. Among the molecular modifications strategies, the prodrug approach is a useful tool to discover new safe NSAIDs. The 1-(2,6-dichlorophenyl)indolin-2-one is a diclofenac prodrug which demonstrated relevant anti-inflammatory properties without gastro ulceration effect. In addition, the prodrug decreases PGE2 levels, COX-2 expression and cellular in… Show more
“…This result supports previous findings that masking the carboxylic acid moiety of NSAIDs gives safer compounds [5,11]. …”
Section: Resultssupporting
confidence: 93%
“…Previous studies have reported other forms of diclofenac prodrugs with lower GI adverse effects, or with properties that aid delivery of the drug to certain distal body organs. For example, 1-(2,6-dichlorophenyl)indolin-2-one is a diclofenac prodrug which demonstrated relevant anti-inflammatory properties without GI ulceration effect [ 11 , 12 ]. Diclofenac ester prodrugs were found to be potent anti-inflammatory drugs with less ulcerogenic potential than the parent diclofenac sodium [ 13 , 14 , 15 , 16 , 17 ].…”
The N-ethoxycarbonylmorpholine moiety was evaluated as a novel prodrug moiety for carboxylic acid containing drugs represented by diclofenac (1). Compound 2, the N-ethoxycarbonylmorpholine ester of diclofenac was synthesized and evaluated as a potential prodrug. The stability of the synthesized prodrug was evaluated in solutions of pH 1 and 7.4, and in plasma. The ester’s half lives were found to be 8 h, 47 h and 21 min in pH 1, pH 7.4 and plasma, respectively. Equimolar doses of diclofenac sodium and its synthesized prodrug were administered orally to a group of rabbits in a crossover study to evaluate their pharmacokinetic parameters. The prodrug 2 shows a similar rate and extent of absorption as the parent drug (1). The ulcerogenicity of the prepared prodrug was evaluated and compared with the parent drug. The prodrug showed less ulcerogenicity as detected by fewer number and smaller size of ulcers. In conclusion, the newly synthesized N-ethoxycarbonylmorpholine ester of diclofenac prodrug showed appropriate stability properties at different pHs, similar pharmacokinetic profile, and much less ulcerogenecity at the GIT compared to the parent drug diclofenac.
“…This result supports previous findings that masking the carboxylic acid moiety of NSAIDs gives safer compounds [5,11]. …”
Section: Resultssupporting
confidence: 93%
“…Previous studies have reported other forms of diclofenac prodrugs with lower GI adverse effects, or with properties that aid delivery of the drug to certain distal body organs. For example, 1-(2,6-dichlorophenyl)indolin-2-one is a diclofenac prodrug which demonstrated relevant anti-inflammatory properties without GI ulceration effect [ 11 , 12 ]. Diclofenac ester prodrugs were found to be potent anti-inflammatory drugs with less ulcerogenic potential than the parent diclofenac sodium [ 13 , 14 , 15 , 16 , 17 ].…”
The N-ethoxycarbonylmorpholine moiety was evaluated as a novel prodrug moiety for carboxylic acid containing drugs represented by diclofenac (1). Compound 2, the N-ethoxycarbonylmorpholine ester of diclofenac was synthesized and evaluated as a potential prodrug. The stability of the synthesized prodrug was evaluated in solutions of pH 1 and 7.4, and in plasma. The ester’s half lives were found to be 8 h, 47 h and 21 min in pH 1, pH 7.4 and plasma, respectively. Equimolar doses of diclofenac sodium and its synthesized prodrug were administered orally to a group of rabbits in a crossover study to evaluate their pharmacokinetic parameters. The prodrug 2 shows a similar rate and extent of absorption as the parent drug (1). The ulcerogenicity of the prepared prodrug was evaluated and compared with the parent drug. The prodrug showed less ulcerogenicity as detected by fewer number and smaller size of ulcers. In conclusion, the newly synthesized N-ethoxycarbonylmorpholine ester of diclofenac prodrug showed appropriate stability properties at different pHs, similar pharmacokinetic profile, and much less ulcerogenecity at the GIT compared to the parent drug diclofenac.
“…The observations that the fractions of the ethanol layer decreased and increased the ulcer indices and curative ratios respectively of the treated rats might be attributed to the anti-oxidant vitamin content and proximate composition of the ethanol layer of the chloroform-ethanol extract of the leaves of D. edulis as shown by the results of their analyses. Also, the finding that diclofenac induced ulcer in all the treated rats is in accord with the reports of Verma et al (2011), Santos et al (2012), Wandale et al (2012) and Khan and Khan (2013). The mechanism by which diclofenac and other NSAIDs cause injury to the gastric mucosa is mainly due to the inhibition of cyclooxygenase and suppression of prostaglandinmediated effects on mucosal protection.…”
In traditional medicine, the leaves of Dacryodes edulis are utilised in the treatment of gastric ulcer and hence, the chloroform and ethanol layers of the chloroform-ethanol extract of the leaves of D. edulis were evaluated for their anti-oxidant vitamin contents and proximate compositions. Based on preliminary investigations, the more promising layer (ethanol layer) was further fractionated and the effects of the fractions on ulcer index and curative ratio of diclofenac-ulcerated Wistar rats were determined using standard methods. The anti-oxidant vitamin contents of the chloroform and ethanol layers showed the following: vitamins A (1.83 ± 0.08 and 1.79 ± 0.08 μg/100 g), C (0.62 ± 0.05 and 0.79 ± 0.03 mg/100 g) and E (1.17 ± 0.07 and 1.04 ± 0.05 mg/100 g) respectively. The proximate compositions of the chloroform and ethanol layers were: moisture (3.15 ± 0.11 and 4.08 ± 0.18%), crude fibre (5.41 ± 0.29 and 5.29 ± 0.27%), ash (5.09 ± 0.27 and 4.12 ± 0.18%), crude fats (4.43 ± 0.13 and 3.98 ± 0.12%), crude proteins (17.24 ± 0.43 and 17.80 ± 0.29%) and carbohydrates (64.68 ± 1.40 and 64.73 ± 1.35%) respectively. Each of the chloroform and ethanol layers of the chloroform-ethanol extract was found to be safe at a dose as high as 5000 mg/kg body weight (b.w). At the two doses (100 and 200 mg/kg b.w), the n-hexane, chloroform, ethyl acetate and methanol fractions of the ethanol layer dose-dependently decreased and increased the ulcer indices and curative ratios respectively of the rats in the test groups when compared with those of the rats in the ulcer-untreated group albeit these effects were not significant (p>0.05) except those of the methanol fraction at the dose of 200 mg/kg b.w. Results of the methanol fraction (200 mg/kg b.w only) were comparable to those of the standard anti-ulcer drug, ranitidine at the dose of 150 mg/kg b.w. The data of this study indicate that the methanol fraction of the ethanol layer of the chloroform-ethanol extract of the leaves of D. edulis possess remarkable antiulcerogenic effect and might serve as source of novel drugs for ulcers in future.
“…The pharmacological activity of NSAIDs is linked to the suppression of prostaglandin biosynthesis from arachidonic acid through inhibiting the enzyme cyclooxygenases [4]. In order to support the results of in vivo study, molecular docking study was executed.…”
The design, synthesis, and development of novel non-steroidal anti-inflammatory drugs (NSAIDs) with better activity and lower side effects are respectable area of research. Novel Diclofenac Schiff's bases (M1, M2, M4, M7, and M8) were designed and synthesized, and their respective chemical structures were deduced using various spectral tools (IR, 1H NMR, 13C NMR, and MS). The compounds were synthesized via Schiff's condensation reaction and their anti-inflammatory activity was investigated applying the Carrageenan-induced paw edema model against Diclofenac as positive control. Percentage inhibition of edema indicated that all compounds were exhibiting a comparable anti-inflammatory activity as Diclofenac. Moreover, the anti-inflammatory activity was supported via virtual screening using molecular docking study. Interestingly compound M2 showed the highest in vivo activity (61.32% inhibition) when compared to standard Diclofenac (51.36% inhibition) as well as the best binding energy score (-10.765) and the virtual screening docking score (-12.142).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.